STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE AND RELATED ANALOGS - PROTEIN-BINDING, LIPOPHILICITY, AND RETENTION IN REVERSED-PHASE LC

被引:6
作者
REICHELOVA, V [1 ]
LILIEMARK, J [1 ]
ALBERTIONI, F [1 ]
机构
[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-17176 STOCKHOLM,SWEDEN
来源
JOURNAL OF LIQUID CHROMATOGRAPHY | 1995年 / 18卷 / 06期
关键词
D O I
10.1080/10826079508009280
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Plasma protein binding of 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFDA), 2-chloro-2'-deoxyadenosine (CdA), 2-fluoro-1-beta-D-arabinofuranosyladenine (F-araA) and structurally related analogues 2-chloro-adenosine (2-Cl-Ado), 5'-chloro-5'-deoxyadenosine (5'-Cl-5'-dAdo), as well as parent nucleosides 2'-deoxyadenosine (dAdo), 1-beta-D-arabinofuranosyladenine (araA) and adenosine (Ado) was determined and correlated with lipophilicity expressed as the logarithm of partition coefficient in n-octanol/water system (log P-o/w). Drug binding to human serum albumin (HSA) was utilized since it is considered to exemplify nonspecific binding of small molecules to other macromolecules. Percentage of drugs bound to HSA increased from 3.5% to 27% following the order of increase in lipophilicity (log P-o/w increased from -0.970 to 0.498). A similar correlation was observed when protein binding was correlated with retention in reversed-phase liquid chromatography (RP-LC) (capacity ratios, k', increased from 0.36 to 1.15), but the elution order of some compounds did not follow the parallel increase in either protein binding or lipophilicity. The introduction of a fluorine at the 2'-arabino position of CdA not only increased the acid stability of CAFDA, but also resulted in a higher binding to HSA (27.0% for CAFDA versus 24.3% for CdA) and much higher lipophilicity (log P of 0.498 for CAFDA compared to 0.025 for CdA).
引用
收藏
页码:1123 / 1135
页数:13
相关论文
共 14 条
[1]  
BABA M, 1993, BIOCHEM PHARMACOL, V45, P2507
[2]   ORAL ANTILYMPHOCYTE ACTIVITY AND INDUCTION OF APOPTOSIS BY 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE [J].
CARSON, DA ;
WASSON, DB ;
ESPARZA, LM ;
CARRERA, CJ ;
KIPPS, TJ ;
COTTAM, HB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2970-2974
[3]   CORRELATION BETWEEN REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND PLASMA-PROTEIN BINDING [J].
GANANSIA, J ;
BIANCHETTI, G ;
THENOT, JP .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 421 (01) :83-90
[4]   DRUG-BINDING IN PLASMA - A SUMMARY OF RECENT TRENDS IN THE STUDY OF DRUG AND HORMONE-BINDING [J].
HERVE, F ;
URIEN, S ;
ALBENGRES, E ;
DUCHE, JC ;
TILLEMENT, JP .
CLINICAL PHARMACOKINETICS, 1994, 26 (01) :44-58
[5]  
JONES DR, 1988, J PHARMACOL EXP THER, V245, P816
[6]   ON THE BIOAVAILABILITY OF ORAL AND SUBCUTANEOUS 2-CHLORO-2'-DEOXYADENOSINE IN HUMANS - ALTERNATIVE ROUTES OF ADMINISTRATION [J].
LILIEMARK, J ;
ALBERTIONI, F ;
HASSAN, M ;
JULIUSSON, G .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1514-1518
[7]  
LILIEMARK J, 1992, BLOOD S, V80, pA471
[8]   2',3'-DIDEOXY-2'-FLUORO-ARA-A - AN ACID-STABLE PURINE NUCLEOSIDE ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) [J].
MARQUEZ, VE ;
TSENG, CKH ;
KELLEY, JA ;
MITSUYA, H ;
BRODER, S ;
ROTH, JS ;
DRISCOLL, JS .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (17) :2719-2722
[9]   ACID-STABLE 2'-FLUORO PURINE DIDEOXYNUCLEOSIDES AS ACTIVE AGENTS AGAINST HIV [J].
MARQUEZ, VE ;
TSENG, CKH ;
MITSUYA, H ;
AOKI, S ;
KELLEY, JA ;
FORD, H ;
ROTH, JS ;
BRODER, S ;
JOHNS, DG ;
DRISCOLL, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :978-985
[10]   COMPARATIVE-STUDY OF INTERACTION MODE OF DIAZEPINES WITH HUMAN SERUM-ALBUMIN AND ALPHA-1-ACID GLYCOPROTEIN [J].
MARUYAMA, T ;
FURUIE, MA ;
HIBINO, S ;
OTAGIRI, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (01) :16-20